Yvonne Nyathi

We are engineering ribosomes and membrane protein quality-control systems to improve folding and expression of antibodies and membrane proteins. In parallel, we are manipulating liquid–liquid phase separation (LLPS) to create programmable intracellular microenvironments that control protein fate. This work will enable reliable production of complex biologics and expand therapeutic possibilities.